ondansetron has been researched along with Decerebrate Posturing in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, RW | 1 |
| Harris, J | 1 |
| Houghton, AK | 1 |
| Dreteler, GH | 1 |
| Wouters, W | 1 |
| Saxena, PR | 1 |
2 other studies available for ondansetron and Decerebrate Posturing
| Article | Year |
|---|---|
Spinal 5-HT-receptors and tonic modulation of transmission through a withdrawal reflex pathway in the decerebrated rabbit.
Topics: Animals; Decerebrate State; Female; Idazoxan; Male; Ondansetron; Piperazines; Pyridines; Quinolines; | 1996 |
Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Anesthesia; Animals; Antihypertensive Agents; Atropine; Bloo | 1990 |